Related Experiment Video

Updated: Jun 28, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Continuous glucose monitoring in infants of very low birth weight

Isabel Iglesias Platas1, Marta Thió Lluch, Neus Pociello Almiñana

  • 1Neonatal Unit, Hospital Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona University, Barcelona, Spain. iiglesias@hsjdbcn.org

Neonatology
|October 31, 2008
PubMed

Insights

Continuous glucose monitoring systems (CGMS) are safe and useful for very low birth weight (VLBW) infants, detecting abnormal glucose levels more frequently than standard sampling. This technology offers valuable insights into infant metabolic health.

Area of Science:

  • Neonatalogy
  • Pediatric Endocrinology
  • Medical Devices

Background:

  • Infants of very low birth weight (VLBW) are susceptible to glucose dysregulation.
  • Current methods for monitoring glucose levels in VLBW infants may not capture the full spectrum of glycemic variability.

Purpose of the Study:

  • To assess the feasibility and efficacy of a continuous glucose monitoring system (CGMS) in VLBW infants.
  • To determine the rate of hyperglycemia and hypoglycemia in this population using CGMS.

Main Methods:

  • A subcutaneous sensor connected to a CGMS was inserted in VLBW infants (<1,500 g, <32 weeks gestation) for up to 7 days.
  • Therapeutic management followed standard protocols during monitoring.

Main Results:

  • CGMS was feasible in 38 VLBW infants (mean gestational age 27.5 weeks, mean birth weight 958.3 g).
  • Hyperglycemia occurred in 57.9% of infants, and hypoglycemia in 36.8%.
  • CGMS provided a safe estimate of glucose levels but not real-time data.

Conclusions:

  • CGMS is a safe and useful tool for estimating glucose levels in VLBW infants.
  • It identified abnormal glucose levels more frequently than expected with standard sampling.
  • CGMS holds potential for understanding the impact of glycemic fluctuations on VLBW infant outcomes.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Simple Continuous Glucose Monitoring in Freely Moving Mice03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Related Concept Videos

Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...